Despite nine AOMs being currently approved for the treatment of obesity, limited clinical trial evidence in older adults predominantly focuses on incretin therapy with glucagon-like peptide-1 receptor agonists (liraglutide, semaglutide, and tirzepatide)
Insulin Sensitivity 02:17:03 Tool: Continuous Glucose Monitors (CGMs) & Awareness, Glucose Spikes 02:24:34 Tool: CGMs, Glycemic Variability, Dawn Effect, Individuality 02:33:10 Sleep
That single timing discipline preserves most of sermorelin's efficacy without requiring lifestyle upheaval
So Robert, today were going to be talking about patient assistance programs and out of pocket costs in copay assistance
Allergic Reactions Some patients taking insulin therapy, including TOUJEO have experienced erythema, local edema, and pruritus at the site of injection